Your browser doesn't support javascript.
loading
Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double-blind placebo-controlled study.
Dickson, Marion C; Walker, Alexandra; Grattan, Clive; Perry, Hayley; Williams, Nicola; Ratia, Nirav; Dewit, Odile; Gisbert, Sophie; Metz, Martin; Maurer, Marcus.
Afiliação
  • Dickson MC; GlaxoSmithKline (GSK), Brentford, Middlesex, UK.
  • Walker A; GlaxoSmithKline (GSK), Brentford, Middlesex, UK.
  • Grattan C; St John's Institute of Dermatology, Guy's Hospital, London, UK.
  • Perry H; GlaxoSmithKline (GSK), Brentford, Middlesex, UK.
  • Williams N; GlaxoSmithKline (GSK), Brentford, Middlesex, UK.
  • Ratia N; GlaxoSmithKline (GSK), Brentford, Middlesex, UK.
  • Dewit O; GlaxoSmithKline (GSK), Brentford, Middlesex, UK.
  • Gisbert S; GlaxoSmithKline (GSK), Brentford, Middlesex, UK.
  • Metz M; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Maurer M; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Br J Clin Pharmacol ; 87(12): 4797-4808, 2021 12.
Article em En | MEDLINE | ID: mdl-34020509

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Urticária Crônica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Urticária Crônica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido